|
1.
|
Potts J, Yogaratnam D. Pirfenidone: a novel agent for the treatment of idiopathic pulmonary fibrosis. Ann Pharmacother. 2013 Mar; 47(3):361-7.
|
|
|
|
|
2.
|
Smith BS, Yogaratnam D, Levasseur-Franklin KE, Forni A, Fong J. Introduction to drug pharmacokinetics in the critically ill patient. Chest. 2012 May; 141(5):1327-36.
|
|
|
|
|
3.
|
Yogaratnam D, Saxer S, Foston TP. Liver failure. Preface. Crit Care Nurs Clin North Am. 2010 Sep; 22(3):xi-xii.
|
|
|
|
|
4.
|
Forni A, Skehan N, Hartman CA, Yogaratnam D, Njoroge M, Schifferdecker C, Lilly CM. Evaluation of the impact of a tele-ICU pharmacist on the management of sedation in critically ill mechanically ventilated patients. Ann Pharmacother. 2010 Mar; 44(3):432-8.
|
|
|
|
|
5.
|
Roberts RJ, Barletta JF, Fong JJ, Schumaker G, Kuper PJ, Papadopoulos S, Yogaratnam D, Kendall E, Xamplas R, Gerlach AT, Szumita PM, Anger KE, Arpino PA, Voils SA, Grgurich P, Ruthazer R, Devlin JW. Incidence of propofol-related infusion syndrome in critically ill adults: a prospective, multicenter study. Crit Care. 2009; 13(5):R169.
|
|
|
|
|
6.
|
Miller MA, Forni A, Yogaratnam D. Propylene glycol-induced lactic acidosis in a patient receiving continuous infusion pentobarbital. Ann Pharmacother. 2008 Oct; 42(10):1502-6.
|
|
|
|
|
7.
|
Yogaratnam D, Miller MA, Smith BS. The effects of liver and renal dysfunction on the pharmacokinetics of sedatives and analgesics in the critically ill patient. Crit Care Nurs Clin North Am. 2005 Sep; 17(3):245-50.
|
|
|
|
|
8.
|
Yogaratnam D, Smith BS, Angood PB, Gandhi PJ. Antifactor Xa levels in four patients with burn injuries who received enoxaparin to prevent venous thromboembolism. Pharmacotherapy. 2004 Dec; 24(12):1793-9.
|
|
|
|
